# Astrazeneca plc (AZN)

- Sector: Healthcare · Industry: Drug Manufacturers General
- SEC CIK: 0000901832 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000901832))
- Full page: https://inspectstocks.com/stocks/azn
- Data as of: price 2026-09-28; newest filing used 2026-07-27; latest fiscal period ended 2026-06-30

## Grade

**A+** on the growth-and-cash rubric, 5 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | passed | $61.4B | $44.5B |
| Revenue growing recently | passed | $61.4B | $58.7B |
| Free cash flow positive | passed | $11.8B |  |
| Free cash flow growing overall | passed | $11.8B | $8.7B |
| Free cash flow growing recently | passed | $11.8B | $9.9B |

Business quality (the + / − mark): 6 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed | 16.7% |  |
| Healthy profit margin | passed | 16.7% |  |
| Strong operating margin | passed | 22.8% |  |
| Good return on equity | passed | 21.0% |  |
| Debt under control | passed | 0.61 |  |
| Turns sales into cash | passed | 19.2% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $61.4B |
| Net income, trailing twelve months | $10.2B |
| Free cash flow, trailing twelve months | $11.8B |
| Net margin | 16.7% |
| Operating margin | 22.8% |
| Return on equity | 21.0% |
| Debt to equity | 0.61 |
| Diluted EPS, trailing twelve months | $6.54 |
| Share price | $166.29 |
| Market value | $259.7B |
| Price / earnings | 25.4x |
| Price / sales | 4.2x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/azn)
- [Financial statements](https://inspectstocks.com/stocks/azn/financials)
- [Competitors](https://inspectstocks.com/stocks/azn/peers)
- [Earnings](https://inspectstocks.com/stocks/azn/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.